These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 27671821)

  • 1. Celastrol and Its Role in Controlling Chronic Diseases.
    Venkatesha SH; Moudgil KD
    Adv Exp Med Biol; 2016; 928():267-289. PubMed ID: 27671821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of autoimmune inflammation by celastrol, a natural triterpenoid.
    Venkatesha SH; Dudics S; Astry B; Moudgil KD
    Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27405485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer.
    Kannaiyan R; Shanmugam MK; Sethi G
    Cancer Lett; 2011 Apr; 303(1):9-20. PubMed ID: 21168266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
    Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
    Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway.
    Tozawa K; Sagawa M; Kizaki M
    Int J Oncol; 2011 Nov; 39(5):1117-22. PubMed ID: 21850367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation.
    Sethi G; Ahn KS; Pandey MK; Aggarwal BB
    Blood; 2007 Apr; 109(7):2727-35. PubMed ID: 17110449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celastrol suppresses experimental autoimmune encephalomyelitis via MAPK/SGK1-regulated mediators of autoimmune pathology.
    Venkatesha SH; Moudgil KD
    Inflamm Res; 2019 Apr; 68(4):285-296. PubMed ID: 30820608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celastrol inhibits IL-1β-induced inflammation in orbital fibroblasts through the suppression of NF-κB activity.
    Li H; Yuan Y; Zhang Y; He Q; Xu R; Ge F; Wu C
    Mol Med Rep; 2016 Sep; 14(3):2799-806. PubMed ID: 27484716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways.
    Mou H; Zheng Y; Zhao P; Bao H; Fang W; Xu N
    Toxicol In Vitro; 2011 Aug; 25(5):1027-32. PubMed ID: 21466843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential medicinal value of celastrol and its synthesized analogues for central nervous system diseases.
    Bai X; Fu RJ; Zhang S; Yue SJ; Chen YY; Xu DQ; Tang YP
    Biomed Pharmacother; 2021 Jul; 139():111551. PubMed ID: 33865016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celastrol Ameliorates Inflammation in Human Retinal Pigment Epithelial Cells by Suppressing NF-κB Signaling.
    Zhang J; Zhou K; Zhang X; Zhou Y; Li Z; Shang F
    J Ocul Pharmacol Ther; 2019 Mar; 35(2):116-123. PubMed ID: 30596540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis.
    Han X; Sun S; Zhao M; Cheng X; Chen G; Lin S; Guan Y; Yu X
    PLoS One; 2014; 9(11):e112470. PubMed ID: 25383959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer effect of celastrol on human triple negative breast cancer: possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways.
    Shrivastava S; Jeengar MK; Reddy VS; Reddy GB; Naidu VG
    Exp Mol Pathol; 2015 Jun; 98(3):313-27. PubMed ID: 25818165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Neurodegenerative Diseases with Bioactive Components of
    Li J; Hao J
    Am J Chin Med; 2019; 47(4):769-785. PubMed ID: 31091976
    [No Abstract]   [Full Text] [Related]  

  • 15. Celastrol suppresses nitric oxide synthases and the angiogenesis pathway in colorectal cancer.
    Gao Y; Zhou S; Pang L; Yang J; Li HJ; Huo X; Qian SY
    Free Radic Res; 2019 Mar; 53(3):324-334. PubMed ID: 30773944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celastrol ameliorates experimental colitis in IL-10 deficient mice via the up-regulation of autophagy.
    Zhao J; Sun Y; Shi P; Dong JN; Zuo LG; Wang HG; Gong JF; Li Y; Gu LL; Li N; Li JS; Zhu WM
    Int Immunopharmacol; 2015 May; 26(1):221-8. PubMed ID: 25858875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celastrol-induced apoptosis in human HaCaT keratinocytes involves the inhibition of NF-κB activity.
    Zhou LL; Lin ZX; Fung KP; Cheng CH; Che CT; Zhao M; Wu SH; Zuo Z
    Eur J Pharmacol; 2011 Nov; 670(2-3):399-408. PubMed ID: 21951963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/Akt-NF-κB signaling pathway.
    Sha M; Ye J; Zhang LX; Luan ZY; Chen YB; Huang JX
    Pharmacology; 2014; 93(1-2):39-46. PubMed ID: 24434352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celastrol pretreatment attenuates rat myocardial ischemia/ reperfusion injury by inhibiting high mobility group box 1 protein expression via the PI3K/Akt pathway.
    Tong S; Zhang L; Joseph J; Jiang X
    Biochem Biophys Res Commun; 2018 Mar; 497(3):843-849. PubMed ID: 29475002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cascade regulation of PPARγ(2) and C/EBPα signaling pathways by celastrol impairs adipocyte differentiation and stimulates lipolysis in 3T3-L1 adipocytes.
    Choi SK; Park S; Jang S; Cho HH; Lee S; You S; Kim SH; Moon HS
    Metabolism; 2016 May; 65(5):646-654. PubMed ID: 27085773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.